Document is current
Any future updates will be listed below
-
Authors
Lyon, Adam
Mays, Charles E.
Borriello, Frank
Telling, Glenn C.
Soto, Claudio
Pritzkow, Sandra
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS079060)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI106705)
Gift from Alloplex Biotherapeutics Inc.
- License Information
-
More Information
Article History
Received: 2 October 2018
Accepted: 1 February 2019
First Online: 19 March 2019
Competing Interests
: Dr. Soto is inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and Vice-President of Amprion Inc, a biotech company focusing on the commercial utilization of PMCA and RT-QuIC for prion diagnosis. Dr. Borriello is CEO and founder of Alloplex Biotherapeutics, Inc.
